Showing results (11-20 of 18) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
International Journal of Radiation Oncology, Biology, Physics|October 1, 2013
Retrospective cohort study of bronchial doses and radiation-induced atelectasis after stereotactic body radiation therapy of lung tumors located close to the bronchial treeKristin Karlsson, Jan Nyman, Pia Baumann, et al.Acta Oncologica (Stockholm, Sweden)|September 20, 2006
Factors important for efficacy of stereotactic body radiotherapy of medically inoperable stage I lung cancer. A retrospective analysis of patients treated in the Nordic countriesPia Baumann, Jan Nyman, Ingmar Lax, et al.Acta Oncologica (Stockholm, Sweden)|September 20, 2006
Dummy run for a phase II study of stereotactic body radiotherapy of T1-T2 N0M0 medical inoperable non-small cell lung cancerEmma Djärv, Jan Nyman, Pia Baumann, et al.Acta Oncologica (Stockholm, Sweden)|January 5, 2011
NTCP modelling of lung toxicity after SBRT comparing the universal survival curve and the linear quadratic model for fractionation correctionBerit M Wennberg, Pia Baumann, Giovanna Gagliardi, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 5, 2008
Stereotactic body radiotherapy for medically inoperable patients with stage I non-small cell lung cancer - a first report of toxicity related to COPD/CVD in a non-randomized prospective phase II studyPia Baumann, Jan Nyman, Morten Hoyer, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 6, 2009
Outcome in a prospective phase II trial of medically inoperable stage I non-small-cell lung cancer patients treated with stereotactic body radiotherapyPia Baumann, Jan Nyman, Morten Hoyer, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 9, 2026
A phase Ib/2a study of fostrox in combination with lenvatinib as second line therapy in patients with advanced hepatocellular carcinomaHong Jae Chon, Jeong Heo, Do Young Kim, et al.Journal of Hepatocellular Carcinoma|October 29, 2024
A Phase 1a/1b Study of Fostroxacitabine Bralpamide (Fostrox) Monotherapy in Hepatocellular Carcinoma and Solid Tumor Liver MetastasesRuth Plummer, Alastair Greystoke, Gregory Naylor, et al.Pageof 2